Resveratrol, piceatannol and analogs inhibit activation of both wild-type and T877A mutant androgen receptor

Title
Resveratrol, piceatannol and analogs inhibit activation of both wild-type and T877A mutant androgen receptor
Authors
Keywords
Resveratrol, Androgen receptor, Prostate cancer, PSA, LNCaP, RWPE
Journal
Publisher
Elsevier BV
Online
2017-09-07
DOI
10.1016/j.jsbmb.2017.08.016

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started